Bausch + Lomb 

$20.93
31
+$0.16+0.77% Thursday 20:00

統計

當日最高
21.06
當日最低
20.55
52週最高
21.69
52週最低
13.16
成交量
774,241
平均成交量
819,453
市值
5.78B
市盈率
-
股息收益率
-
股息
-

即將到來

收益

30Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0
0.08
0.16
0.24
預期每股收益
0.155526
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 BLCO 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

20.14$平均價格目標
最高估價為 $25。
來自過去 6 個月內的 8 個評級。這不是投資建議。
買入
63%
持有
38%
賣出
0%

關於

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Show more...
首席執行官
員工
13000
國家
CA
ISIN
CA0717051076

上市公司